Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ERIC A ADAMS Insider Profile
4 Followers
ERIC A ADAMS, President & CEO, Director at InMed Pharmaceuticals, holds 43.96K shares in InMed Pharmaceuticals (Ticker: INM). Most recently, ERIC A ADAMS Bought $41,600 shares of InMed Pharmaceuticals on Feb 21, 2024 for an estimated value of 14.56K.
ERIC A ADAMS InMed Pharmaceuticals (INM)President & CEO, Director
InMed Pharmaceuticals (INM)
President & CEO, Director
Ranked #95,674 out of 100,202 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-78.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that ERIC A ADAMS holds in companies
Most Profitable Insider Trade
The most profitable trade made by ERIC A ADAMS
ERIC A ADAMS's Trading History
List of latest transactions for each holding click on a transaction to see ERIC A ADAMS's performance on stock
You May Also Like
ERIC A ADAMS insider profile FAQ
What is the percentage of profitable transactions made by ERIC A ADAMS?
The percentage of profitable transactions made by ERIC A ADAMS is 0%.
What is the average return per transaction made by ERIC A ADAMS?
The average return per transaction made by ERIC A ADAMS is -78.00%.
What stocks does ERIC A ADAMS hold?
ERIC A ADAMS holds: INM stocks.
What was ERIC A ADAMS’s latest transaction?
ERIC A ADAMS latest transaction was an Informative Buy of $14.56K.
What was ERIC A ADAMS's most profitable transaction?
ERIC A ADAMS’s most profitable transaction was an Informative Buy of INM stock on February 21, 2024. The return on the trade was -45.50%.
What is ERIC A ADAMS's role in InMed Pharmaceuticals?
ERIC A ADAMS's role in InMed Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.